Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Melatonin agonists from Takeda

Feb. 26, 1997

5-HT2C antagonists from Roche

Feb. 26, 1997

MS&D discloses tachykinin antagonists

Feb. 26, 1997

Watson's analgesic receives FDA approval

Feb. 25, 1997

Novo Nordisk prepares compounds with high affinity for 5-HT2C receptors

Feb. 25, 1997

Acorda and Elan to collaborate on spinal cord injury treatment

Feb. 24, 1997

Licenses offered for vasospasm therapy

Feb. 24, 1997

NIH seeks licensees for antispasmodic immunotoxin

Feb. 24, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Sanofi Winthrop reveals calpain inhibitors

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...